tiprankstipranks
Trending News
More News >
Medlive Technology Co., Ltd. (HK:2192)
:2192
Hong Kong Market

Compare Medlive Technology Co., Ltd. (2192) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Medlive Technology Co., Ltd.
HK$9.83
HK$7.54B
21.39
17.07%
Shanghai Pharmaceuticals Holding Co
HK$11.91
HK$65.17B
7.25
-3.72%
3 Buy
0 Hold
1 Sell
Moderate Buy
Sinopharm Group Co
HK$20.28
HK$65.16B
8.86
1.61%
0 Buy
0 Hold
1 Sell
Moderate Sell
ClouDr Group Limited
HK$1.00
HK$566.22M
-0.51
-31.25%
IVD Medical Holding Limited
HK$3.85
HK$2.37B
12.59
-20.17%
Charmacy Pharmaceutical Co., Ltd. Class H
HK$7.31
HK$626.40M
12.01
-37.97%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2192
Medlive Technology Co., Ltd.
10.22
1.95
23.58%
HK:2607
Shanghai Pharmaceuticals Holding Co
11.90
0.13
1.11%
HK:1099
Sinopharm Group Co
20.88
1.55
8.04%
HK:9955
ClouDr Group Limited
0.88
-0.34
-27.87%
HK:1931
IVD Medical Holding Limited
1.46
-0.37
-20.22%
HK:2289
Charmacy Pharmaceutical Co., Ltd. Class H
5.80
-2.91
-33.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts